SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 212 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $178,205 | -31.2% | 201,134 | +22.0% | 0.00% | – |
| Q3 2022 | $259,000 | -33.6% | 164,808 | -15.1% | 0.00% | – |
| Q2 2022 | $390,000 | -9.1% | 194,117 | +5.2% | 0.00% | – |
| Q1 2022 | $429,000 | -54.6% | 184,609 | -9.0% | 0.00% | – |
| Q4 2021 | $944,000 | -36.9% | 202,889 | +3.4% | 0.00% | -100.0% |
| Q3 2021 | $1,496,000 | -17.6% | 196,221 | +4.7% | 0.00% | 0.0% |
| Q2 2021 | $1,815,000 | +17.9% | 187,432 | +0.7% | 0.00% | 0.0% |
| Q1 2021 | $1,539,000 | +1.9% | 186,056 | -16.0% | 0.00% | 0.0% |
| Q4 2020 | $1,511,000 | +5.1% | 221,528 | +71.6% | 0.00% | 0.0% |
| Q3 2020 | $1,438,000 | +135.7% | 129,067 | +32.7% | 0.00% | – |
| Q2 2020 | $610,000 | +577.8% | 97,250 | +99.1% | 0.00% | – |
| Q1 2020 | $90,000 | -41.9% | 48,846 | +5.3% | 0.00% | – |
| Q4 2019 | $155,000 | +103.9% | 46,367 | +26.1% | 0.00% | – |
| Q3 2019 | $76,000 | -80.5% | 36,777 | -75.0% | 0.00% | – |
| Q2 2019 | $390,000 | -66.4% | 146,830 | -40.0% | 0.00% | -100.0% |
| Q1 2019 | $1,161,000 | -48.9% | 244,749 | -74.2% | 0.00% | -50.0% |
| Q4 2018 | $2,273,000 | -54.9% | 947,581 | -17.4% | 0.00% | +100.0% |
| Q3 2018 | $5,045,000 | -22.3% | 1,146,808 | +27.1% | 0.00% | -50.0% |
| Q2 2018 | $6,493,000 | +34.4% | 901,935 | -3.8% | 0.00% | 0.0% |
| Q1 2018 | $4,830,000 | +1164.4% | 937,906 | +832.1% | 0.00% | – |
| Q4 2017 | $382,000 | -37.1% | 100,621 | -71.9% | 0.00% | – |
| Q3 2017 | $607,000 | +28.3% | 357,941 | +51.0% | 0.00% | – |
| Q2 2017 | $473,000 | +20.1% | 237,047 | +137.2% | 0.00% | – |
| Q1 2017 | $394,000 | -26.2% | 99,952 | -8.5% | 0.00% | – |
| Q4 2016 | $534,000 | -31.7% | 109,274 | +7.9% | 0.00% | -100.0% |
| Q3 2016 | $782,000 | -5.0% | 101,261 | -31.4% | 0.00% | 0.0% |
| Q2 2016 | $823,000 | -30.4% | 147,543 | -33.0% | 0.00% | 0.0% |
| Q1 2016 | $1,182,000 | -39.4% | 220,133 | -1.8% | 0.00% | 0.0% |
| Q4 2015 | $1,950,000 | -3.9% | 224,147 | -7.4% | 0.00% | -50.0% |
| Q3 2015 | $2,029,000 | -57.0% | 242,068 | -9.7% | 0.00% | -33.3% |
| Q2 2015 | $4,722,000 | +83.6% | 268,096 | +20.4% | 0.00% | +50.0% |
| Q1 2015 | $2,572,000 | +11.5% | 222,595 | -2.9% | 0.00% | +100.0% |
| Q4 2014 | $2,306,000 | +259.2% | 229,195 | +61.2% | 0.00% | – |
| Q3 2014 | $642,000 | -35.5% | 142,195 | -3.7% | 0.00% | -100.0% |
| Q2 2014 | $995,000 | +2663.9% | 147,595 | +5128.3% | 0.00% | – |
| Q1 2014 | $36,000 | +800.0% | 2,823 | +406.8% | 0.00% | – |
| Q4 2013 | $4,000 | – | 557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |